MMJ PhytoTech to initiate Phase II trial of PTL201 to treat MS symptoms

MMJ PhytoTech ’s Israeli division PhytoTech Therapeutics has obtained approvals from Ministry of Health and the Sheba Hospital regulatory body Helsinki, to initiate a Phase II clinical trial of its PTL201 for the treatment of spasticity related sympto…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news